|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 前列腺癌骨髓微转移的免疫细胞化学检测显示文摘目的:探讨前列腺癌患者骨髓中微转移癌细胞的检测方法。方法:术前采集前列腺癌59例的骨髓标本并收集相关临床资料,应用细胞角蛋白的免疫细胞化学方法进行检测,并将结果与TNM G分期(级)进行相关分析。结果:骨髓中CK+细胞检出率为25.4%,除G3/4组阳性率(45.5%)明显高于G1/2组(12.5%,P=0.01)外,其余各组间的阳性率,差异均无显著性意义。结论:免疫细胞化学方法可作为检测骨髓中隐蔽的微转移肿瘤细胞的一种敏感的标准方法,肿瘤细胞的分化程度可能与其离开原发灶发生播散的能力有关,该指标是一个独立的危险因素,对预后评估和治疗方法的选择与确定有指导意义。 | 黄瑜峰 Oberneder R Riesenberg R Buchner A Hofstetter A | 2001 | 临床泌尿外科杂志2001，16，5： | 2 |
| 2 | Use of hydro-jet cutting for lap-aroscopic partial nephrectomyy in a porcine model 显示文摘 | CORVIN S OBERNEDER R ADAM C | 2001 | Urology2001，58，： | 1 |
| 3 | Local recurrence in patients after radical cystectomy and orthotopic ileal neobladder:impact on function显示文摘 | Oberneder R Staudte S Waidelich R | | 0，，02： | 1 |
| 4 | 根治术前后肿瘤细胞在骨髓中播散的自动显微图像研究显示文摘目的:对比研究泌尿系肿瘤患者根治术前后骨髓中散在的微转移肿瘤细胞。方法:术前及术后采集肾癌、前列腺癌和尿道膀胱癌共102例患者的骨髓标本,应用细胞角蛋白的免疫细胞化学方法及自动显微图像对比检测分析。结果:根治术前后骨髓中微转移肿瘤细胞检出率密切相关(P<0.005),术前肿瘤细胞总检出率为31.4%,术后为34.3%,无显著性差别(P=0.65);三种泌尿肿瘤患者根治术前后检出率比较亦均无明显差别(P=0.70P=0.10P=0.59) 但术后检出的肿瘤细胞数多于术前者总数分别为64和44,3个以上阳性细胞仅在术后出现,两次阳性的细胞数均值分别为1.31±0.48和1.95±1.02(P=0.009 9)12例患者手术8天后检出细胞数(22)明显多于术前者(7),P=0.01。结论:免疫细胞化学方法可作为检测骨髓中隐蔽的微转移肿瘤细胞的敏感标准方法,根治术前后检出率虽无明显改变 但术后及手术8天以后检出细胞数明显多于术前者,提示手术可能会促使肿瘤细胞在骨髓中的播散。 | 黄瑜峰 刘立义 Riesenberg R Oberneder R Buchner A Hofstetter A 李雅玲 | 2001 | 中国肿瘤临床2001，28，1： | 1 |
| 5 | In vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP), and vaporization-resection of the prostate (TUVRP)显示文摘 | Reich O Corvin S Oberneder R | 2002 | Urol Res2002，30，1： | 1 |
| 6 | In vitro comparison of transurethral vaporization of the prostate (TUVP),resection of the prostate (TURP),and vaporization-resection of the prostate (TUVRP)显示文摘 | Reich O Corvin S Oberneder R | 2002 | Urol Res2002，30，1： | 1 |
| 7 | Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells显示文摘 | Bernhard Frankenberger Sybille Regn Christiane Geiger Elfriede Noessner Christine S. Falk Heike Pohla Miran Javorovic Tobias Silberzahn Susanne Wilde Alexander Buchner Michael Siebels Ralph Oberneder Gerald Willimsky Antonio Pezzutto Thomas Blankenstein D | 2005 | World Journal of Urology2005，，3： | 1 |
| 8 | Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer显示文摘 | R. Oberneder R. Riesenberg M. Kriegmair U. Bitzer R. Klammert P. Schneede A. Hofstetter G. Riethmüller K. Pantel | 1994 | Urological Research1994，，1： | 1 |
| 9 | In Vitro Comparison of Tranurthral Vaporization of the Prostate(TUVP),Resection of the Prostate (TURP),and Vaporization-Resection of the Prostate(TUVRP)显示文摘 | RERICH O CORVIN S OBERNEDER R | 2002 | Urol Res2002，30，： | 1 |
| 10 | A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX) and interferon-alpha-2a in metastatic renal cell carcinoma patients显示文摘 | Siebels M Rohrmann K Oberneder R | | 0，，01： | 1 |
| 11 | In vitro comparison of transurethral vaporization of the prostate(TUVP),resection of the prostate(TURP),and vaporization-resection of the prostate(TUVRP)显示文摘 | Reich O Corvin S Oberneder R | 2002 | Urol Res2002，30，： | 1 |
| 12 | Use of hydro-jet cutting for laparoscopic partial nephrec- tomy in a porcine model显示文摘 | CORVIN S OBERNEDER R ADAM C | 2001 | Urology2001，58，： | 1 |
| 13 | In vitro comparison of transurethral vaporization of the prostate (TUVP) ,resection of the prostate( TURP), and vaporization - resection of the prostate ( TCVRP)显示文摘 | Reich O Corvin S Oberneder R el al | 2002 | Urol Res2002，30，1： | 1 |
| 14 | A clinical phase Ⅰ/Ⅱ trial with the monoclonal antibody cG250 ( RENCAREX ) and inter- feron-alpha-2a in metastatic renal cell carcinoma patients显示文摘 | Siebels M Rohrmann K Oberneder R | 2011 | World J Urol2011，29，1： | 1 |
| 15 | Lnvitro comparison of transurethral vaporization of the prostate (TUVP),resection of the prostate (TURP), and vaporization - resection of the prostate (TUVRP) 显示文摘 | REICH O CORVIN S OBERNEDER R | 2002 | Urol Res2002，30，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员